SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to a massive volume spike and price surge, triggering multiple trading halts, as community discussion focuses on its extremely low float and high insider ownership for a potential short squeeze. Many are comparing it to recent explosive SPACs, with speculative targets suggesting significant upside, fueled by talking points like a rumored "sex toy manufacturer" acquisition. The stock's momentum reflects its position as a key play in the current "SPAC mania" for micro-float tickers.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is rapidly trending due to a potent combination of its extremely low share float and a potential short squeeze, driving significant momentum. The recent announcement of a strategic manufacturing partnership, expected to boost production margins, further amplifies investor interest. The community is actively discussing strong buying defense and a "textbook" short squeeze play as the company continues to expand global adoption of its fingerprint drug screening technology.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings (ONDS) is trending due to recent autonomous system orders and the FCC's ban on foreign-made drones, which significantly boosts its role in the domestic market. The community is actively discussing a potential short squeeze and anticipating a significant price breakout, with many seeing dips as buying opportunities. This positions Ondas as a crucial player in the growing defense and critical infrastructure sectors for autonomous and counter-drone solutions.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after the FDA issued a Complete Response Letter for its relacorilant hypertension indication, triggering a sharp stock decline and intense community debate. Investors are divided, with many viewing the sell-off as an overreaction given the company's existing profitable drug and other pipeline programs, while others express caution regarding potential delays and future prospects.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending following its recent FDA approval of NEREUS, the first new motion sickness treatment in over four decades, validating a significant pipeline asset. Community discussion highlights the drug's broader potential for GLP-1 induced nausea, fueling speculation of substantial upside, a potential short squeeze, and even a buyout, given the company's strong financial standing and additional upcoming regulatory catalysts.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following its CEO's strategic insights on CNBC and news of spinning off its cloud business into ChronoScale, a move seen by many as unlocking significant value and clarifying its pure-play AI data center infrastructure focus. The community is actively discussing sustained demand from hyperscalers and strong analyst confidence ahead of its upcoming earnings report, fueling bullish sentiment despite recent price volatility. This strategic realignment aims to capitalize on the booming AI infrastructure market with a clearer business model and substantial contracted revenue.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst a wave of strong bearish sentiment, largely attributed to sustained selling pressure, high short interest, and year-end tax loss harvesting. The community is actively discussing the recent FDA approval of Novo Nordisk's oral Wegovy pill, seeing a potential for partnership and a significant catalyst for HIMS's future growth in GLP-1 offerings, alongside its ongoing expansion in D2C lab testing and international markets. Despite current frustration, many long-term investors are using this dip as a buying opportunity, anticipating a strong reversal.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after rival Corcept Therapeutics received an FDA Complete Response Letter for its Cushing's syndrome drug, effectively removing a near-term competitor for Xeris's Recorlev. The community is buzzing with bullish sentiment, emphasizing Recorlev's blockbuster potential and the significant undervaluation of XERS, further supported by advancing pipeline assets like XP-8121 and robust gross margins.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA's acceptance and priority review of its supplemental New Drug Application for AXS-05 in Alzheimer's disease agitation, with an action date anticipated in the near future. This significant regulatory milestone, combined with growing sales of its existing CNS therapies like Auvelity, has ignited immense optimism within the community, with many anticipating substantial long-term value and discussing breakthrough potential.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

Motorola Solutions ($MSI) is trending following strategic acquisitions in advanced communications and AI-powered video monitoring, reinforcing its leadership in mission-critical technology for public safety and enterprise security. Community sentiment reflects a strong focus on institutional accumulation, evident in large dark pool trades and technical indicators suggesting the stock is oversold, signaling potential for a reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>GE Vernova is emerging as a standout performer thanks to accelerating orders, strong backlogs, margin gains, and rising free cash flow.</li><li>The company is benefiting from surging data-center demand and expanding grid investments.</li><li>The company recently issued a stronger-than-expected near and medium-term outlook at its investor event.</li></ul>Once considered a bellwether of the economy, given the diverse businesses under its fold, GE was beginning to feel the weight of an unwieldy organization; its fundamentals suffered, and it was booted from the Dow Jones Industrial Average in 2018 after being part of the blue-chip average for more than a century.Desperate times call for desperate measures. The company chose to take a bolder approach to streamline operations by effecting a tripartite split: the parent company was renamed GE Aerospace, GE Vernova (focused on energy), and GE Healthcare.&nbsp;&nbsp;While the plan was mooted and communicated to the investors in November 2021, GE Healthcare was spun off in 2023, followed by the separation of GE Vernova, leaving parent GE as a pure-play aerospace company.&nbsp;Far from a risky experiment, GE’s restructuring is emerging as one of Wall Street’s most effective value unlocks — with spin-off unit Vernova’s (GEV) AI-driven breakout validating the bet.&nbsp;<h2 class="st-heading-2">GEV’s Businesses</h2>The company provides power generation products, such as gas turbines, to end markets including pulp &amp; paper mills, mines, data centers, oil &amp; gas, and hospitals. By energy sources, power accounted for roughly half of the company’s revenues in the September quarter, with wind and electrification contributing approximately 25% each.<h2 class="st-heading-2">GEV Lands In Data Center Sweetspot</h2>When the company released its third-quarter results in late October, CEP Scott Strazik sounded positive about its order flow and backlogs:<blockquote>“Our growth trajectory is accelerating and the demand environment for our equipment and services remains strong with $16 billion in backlog growth year-to-date. Our Gas Power equipment backlog and slot reservation agreements increased from 55 to 62 gigawatts sequentially, and our Electrification equipment backlog increased $6.5 billion year-to-date, to approximately $26 billion.”</blockquote>The 55% order growth was exemplary by any standards. And more importantly, the company also reported significant margin expansion and positive free cash flow.<img src="https://news.stocktwits-cdn.com/GE_Vs_Accelerating_Revenue_Growth_png_bd4dfad687.webp" alt="GEVs_Accelerating_Revenue_Growth.png">Source: Fiscal.aiOn the earnings call, Strazik called data centers among the company’s “new archetype of customers.” He named data center growth as one of the three drivers of grid investment growth, which, in turn, is increasing demand for its products. He also noted that the company signed its first technology collaboration funding agreement with a hyperscaler for scope inside the data center.To tap into the data center opportunity, the company agreed to acquire the remaining 50% of the Prolec GE joint venture from its partner, Xignux, by paying $5.275 billion in cash and debt. The company sounded upbeat about the complete ownership assumption:<blockquote>“This is a business we know well and is an attractive acquisition for GE Vernova consolidating a leading grid equipment provider that produces transformers to serve North American utilities, industrials and data centers.”</blockquote>The deal is expected to close by mid-2026.<h2 class="st-heading-2">Which GE Splinter Company’s Stock Fares Better?</h2>For the year-to-date period,&nbsp;<a href="https://stocktwits.com/symbol/GEV">GEV stock</a> has gained 90.41%, outperforming the shares of&nbsp;<a href="https://stocktwits.com/symbol/GE">GE Aerospace (GE)</a> (up 72%) and&nbsp;<a href="https://stocktwits.com/symbol/GEHC">GE Healthcare</a> (GEHC) (up 6.5%).<img src="https://news.stocktwits-cdn.com/GEV_GE_GEHC_stock_returns_png_aa882a8cc6.webp" alt="GEV GE GEHC stock returns.png">Source: KoyfinGEV stock has been on a broader uptrend since its public listing. A mini uptrend that began when the stock hit a bottom in April lasted through late July, and since then, the stock has been broadly consolidating. Since its March 27, 2024 listing, the stock is up about 380%.<img src="https://news.stocktwits-cdn.com/GEV_since_IPO_png_8e4c1d1364.webp" alt="GEV since IPO.png">Source: KoyfinRetail sentiment toward GEV stock has remained muted. From ‘bullish’ a year ago, sentiment deteriorated to ‘bearishness,’ before ticking higher, although only to ‘neutral’ since this week.&nbsp;<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_10_at_8_20_42_AM_png_c460d562bb.webp" alt="Screenshot 2025-12-10 at 8.20.42 AM.png"><h2 class="st-heading-2">Raft Of Positive Headlines</h2>GEV stock has begun another uptrend in late November, buoyed by positive headlines. At the start of December, the company announced a $400 million funding grant to the Tennessee Valley Authority to continue accelerating the deployment of GE Vernova Hitachi Nuclear Energy’s BWRX-300 small modular reactor (SMR). Strazik said the BWRX-300 is the only commercial SMR technology currently being built in the Western world.In its 2025 Investor Update, the company reaffirmed its 2025 revenue and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) margin guidance. The company lifted its 2028 revenue outlook to low-double-digit organic growth from the high-single-digit growth it had forecast earlier.It lifted its 2025 free cash flow guidance to $3.5 billion to $4 billion, which is expected to rise to $4 billion to $4.5 billion in 2026 and more than $22 billion by 2028.Separately, GEV doubled its quarterly dividend to $0.50 per share and increased its buyback authorization to $10 billion.GEV is also set to benefit from the rare-earth scramble, as China restricts the supply of these key materials used in multiple end products. Strazik reportedly&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/energy/ge-vernova-working-with-us-government-boost-stocks-rare-earth-yttrium-2025-12-10/">said</a> at the Investor event that the company is working with the government to increase yttrium stockpiles, a rare-earth element.&nbsp;Following the investor update, GEV received a few upgrades and a slew of price-target hikes, according to summaries of notes from the Fly.&nbsp;According to Koyfin, the average price target for GEV is $692.14, suggesting a 11% upside potential from current levels. Wall Street firms RBC Capital Markets and Oppenheimer upgraded the stock, assigning it bullish-equivalent ratings. With upward price target adjustments, the new price targets now range from $775 to $1,000 (JPMorgan).BMO Capital Markets analysts called the medium-term projections better-than-expected and viewed the guidance as conservative, as it excluded pre-synergy EBITDA of $800 million from the pending deal to take full ownership of Prolec.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-india-is-becoming-the-new-battleground-for-microsoft-google-and-amazon/cLIHcY2REVc">Big Tech’s AI Gold Rush Heads East: Why India Is Becoming The New Battleground For Microsoft, Google And Amazon</a>

GE Vernova's 9HA gas turbine model is on display during the 7th China International Import Expo (CIIE) on November 8, 2024, in Shanghai, China.

GE’s Great Breakup Wasn’t A Gamble — It Was A Masterstroke. And Vernova’s AI-Driven Surge Proves It

GEV has rapidly transformed into a high-momentum energy and infrastructure powerhouse, capitalizing on explosive demand from data centers, grid modernization needs, and nuclear investments.

Equity

GEV has rapidly transformed into a high-momentum energy and infrastructure powerhouse, capitalizing on explosive demand from data centers, grid modernization needs, and nuclear investments.


Should You Invest in the iShares U.S. Industrials ETF (IYJ)?

Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?

Should You Invest in the First Trust RBA American Industrial Renaissance ETF (AIRR)?

Should You Invest in the Vanguard Industrials ETF (VIS)?

Is Invesco S&P 500 Equal Weight Industrials ETF (RSPN) a Strong ETF Right Now?

Should You Invest in the First Trust Industrials/Producer Durables AlphaDEX ETF (FXR)?

Should You Invest in the Invesco S&P 500 Equal Weight Industrials ETF (RSPN)?

Energy Vault Holdings Inc.’s (NRGV) stock jumped by more than 9% on Wednesday morning after the renewable power company said it had partnered with nuclear-power technology company NuCube Energy.The two companies will collaborate to accelerate the deployment of NuSun – NuCube’s small, modular microreactor designed to power industrial and data-center applications – along with accompanying energy storage systems, by the end of 2028 or early 2029.Energy Vault said that it will leverage its expertise in advanced material science technologies from its gravity storage research and development to expedite the development of shielding and containment systems used in NuSun.The company will create and install custom software in its VaultOS platform to allow joint control of its B-VAULT energy storage system and NuSun's hardware.&nbsp;This system will store excess energy during low demand and release it during peak demand, ensuring AI data centers run smoothly 24/7.&nbsp;The integration will also allow for larger, more efficient energy projects and better management of energy needs across multiple units.The move comes amid growing demand for sustainable, reliable energy solutions to support hyperscalers such as Microsoft (MSFT) and Amazon.com (AMZN), which are increasingly prioritizing independent energy sources over local utility grids.<figure class="image"><img style="aspect-ratio:644/146;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_15_104430_8342efb923.png" alt="Screenshot 2025-01-15 104430.png" width="644" height="146"><figcaption>Energy Vault Holdings Inc. Sentiment and Message Volume on Jan.15 as of 10:45 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around Energy Vault remained in the ‘neutral’ territory as message volume remained at ‘normal’ levels.&nbsp;However, some investors on the platform expressed optimism about the company's positioning within the carbon-free energy sector after the partnership, highlighting its potential as data centers and high-performance computing (HPC) campuses expand.One Stocktwits user remarked on the growing opportunity for firms providing nuclear and renewable energy solutions to replace traditional energy sources.<stembedurl>https://stocktwits.com/rtaker/message/600072742</stembedurl>Analysts remain cautiously optimistic about Energy Vault’s prospects, with three of the four covering analysts rating the stock as a ‘Buy.’&nbsp;The average price target, according to Koyfin, stands at $2.13 per share.The stock's recent gains pushed its one-year performance to a 12% increase.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wisekey-sealsq-stocks-surge-spacex-quantum-ready-satellite/chGqY5RRV8">WISeKey, SEALSQ Shares Rally On Successful Space X Launch Of Quantum-Ready Satellite : Retail Mood Remains Tepid</a>

Energy Vault Stock Rise On NuCube Partnership For Modular Nuclear Reactors: Retail Applauds Carbon-Free Energy Push

The two will collaborate to develop NuSun, NuCube’s small, modular microreactor, which is intended to power industrial and data-center applications.

Energy Vault Shares Rise On NuCube Partnership For Modular Nuclear Reactors: Retail Applauds Carbon-Free Energy Push

The two will collaborate to develop NuSun, NuCube’s small, modular microreactor, which is intended to power industrial and data-center applications.


VIS
Vanguard Industrials ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VIS News

VISVanguard Industrials ETF